Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Rank in Stocks #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Share Price
$72.44
Last synced: 2026-08-24
Market Cap
$20.13B
Change (1 day)
1.25%
Change (1 year)
17.60%
Country
DK
Trade Novonesis (Novozymes) B (NSISBC)
EPS for Novonesis (Novozymes) B (NSISBC)
EPS as of 2026 TTM: 0
According to Novonesis (Novozymes) B latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Novonesis (Novozymes) B from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.56 -
GB
- -
FR
$10.95 -
US
$7.50 -
US
$-0.21 -
US